<DOC>
	<DOC>NCT00902980</DOC>
	<brief_summary>This is a multicentre, observational, non-interventional, retrospective analysis by chart review.</brief_summary>
	<brief_title>Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics</brief_title>
	<detailed_description>This study will compare differences in patient and graft related outcomes in renal transplant recipients followed in regional transplant centers versus satellite clinics.</detailed_description>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>Patient is at least 18 months post transplant Patient had the current transplant during the period 1 July 1997 to no less than 18 months prior to chart review Patient is currently on tacrolimus/MMF or AZA or cyclosporine/MMF or AZA based immunosuppressive therapy Patient is not a recipient of dual kidney or multi organ transplant Patient has a functioning graft (i.e. patient does not require dialysis) Patient is recipient of a renal transplant including living or cadaveric, related or nonrelated, or pediatric en bloc kidneys, but excluding kidneypancreas transplant recipients Patient received the current transplant at one of six identified regional transplant centers Patient is currently followed in a regional or satellite community based nephrology clinic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Kidney transplantation</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>